THANKTIVA THANKTASTIC ANKTIVA Trademark

Trademark Overview

On Tuesday, March 19, 2024, a trademark application was filed for THANKTIVA THANKTASTIC ANKTIVA with the United States Patent and Trademark Office. The USPTO has given the THANKTIVA THANKTASTIC ANKTIVA trademark a serial number of 98456624. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, April 2, 2025. This trademark is owned by ImmunityBio, Inc.. The THANKTIVA THANKTASTIC ANKTIVA trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical preparations and substances for the prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; biological preparations for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases and infectious diseases in the fields of immunotherapy and immuno-oncology; anti-infectives for medical use for the treatment and prevention of immunologic dysfunction, autoimmune diseases and infectious diseases

Medical services; medical information; providing a website featuring medical information in the fields of pharmaceuticals, immunotherapy, immuno-oncology, cancer, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases

Medical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases
thanktiva thanktastic anktiva

General Information

Serial Number98456624
Word MarkTHANKTIVA THANKTASTIC ANKTIVA
Filing DateTuesday, March 19, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateWednesday, April 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical preparations and substances for the prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; pharmaceutical and biological preparations for use in targeted immunotherapy for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases, and infectious diseases; biological preparations for the treatment and prevention of immunologic dysfunction, cancer, autoimmune diseases and infectious diseases in the fields of immunotherapy and immuno-oncology; anti-infectives for medical use for the treatment and prevention of immunologic dysfunction, autoimmune diseases and infectious diseases
Goods and ServicesMedical services; medical information; providing a website featuring medical information in the fields of pharmaceuticals, immunotherapy, immuno-oncology, cancer, autoimmune diseases, and infectious diseases; providing medical information relating to pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases
Goods and ServicesMedical and pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases; product development in the fields of pharmaceuticals, immunotherapy, immuno-oncology, and the treatment and prevention of cancer, autoimmune diseases, and infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunityBio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Tuesday, March 19, 2024NEW APPLICATION ENTERED
Wednesday, August 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 3, 2024NON-FINAL ACTION E-MAILED
Thursday, October 3, 2024NON-FINAL ACTION WRITTEN
Thursday, September 26, 2024ASSIGNED TO EXAMINER
Thursday, October 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 30, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, December 30, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Tuesday, April 1, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 1, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 2, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

anktiva thanktastic thanktiva diseases infectious autoimmune cancer prevention treatment medical immunotherapy oncology immuno